NASDAQ:PLRZ Polyrizon (PLRZ) Stock Price, News & Analysis $1.12 -0.05 (-4.27%) As of 03:19 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Polyrizon Stock (NASDAQ:PLRZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Polyrizon alerts:Sign Up Key Stats Today's Range$1.11▼$1.1650-Day Range$0.96▼$1.2552-Week Range$0.55▼$1,200.00Volume216,313 shsAverage Volume2.90 million shsMarket Capitalization$6.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel. Read More Receive PLRZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polyrizon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PLRZ Stock News HeadlinesPolyrizon (NASDAQ:PLRZ) Stock Price Up 5.4% - Should You Buy?October 14 at 3:15 AM | americanbankingnews.comPolyrizon Reports Positive Pre-Clinical Results for PL-14 Allergy BlockerOctober 6, 2025 | tipranks.comRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.October 15 at 2:00 AM | Stansberry Research (Ad)Polyrizon Ltd. Announces Positive Pre-Clinical Results for PL-14 Allergy Blocker FormulationOctober 6, 2025 | quiverquant.comQPolyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking EfficacyOctober 6, 2025 | globenewswire.comPolyrizon submits pre-submission package to FDA for PL-14September 20, 2025 | msn.comPolyrizon Advances Allergy Treatment with FDA Submission for PL-14September 19, 2025 | tipranks.comPolyrizon Ltd. Submits Pre-Submission Package to FDA for PL-14 Allergy Blocker DevelopmentSeptember 19, 2025 | quiverquant.comQSee More Headlines PLRZ Stock Analysis - Frequently Asked Questions How have PLRZ shares performed this year? Polyrizon's stock was trading at $542.50 on January 1st, 2025. Since then, PLRZ stock has decreased by 99.8% and is now trading at $1.12. When did Polyrizon's stock split? Polyrizon shares reverse split on Tuesday, May 27th 2025.A 1-250 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. When did Polyrizon IPO? Polyrizon (PLRZ) raised $4 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share. How do I buy shares of Polyrizon? Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:PLRZ Previous SymbolNASDAQ:PLRZ CIK1893645 Webwww.polyrizon-biotech.com Phone972-55-433-5665FaxN/AEmployeesN/AYear Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio44.04 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$315.07 per share Price / Book0.00Miscellaneous Outstanding Shares5,990,000Free FloatN/AMarket Cap$6.83 million OptionableN/A BetaN/A Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:PLRZ) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
